click below
click below
Normal Size Small Size show me how
MS Drugs
Multiple Sclerosis
| Question | Answer |
|---|---|
| two main groups of disease-modifying drugs: | immunomodulators and immunosuppressants |
| immunomodulators include: | interferon beta, glatiramer acetate, natalizumab, and fingolimod |
| mitoxantrone | the major immunosuppressant in use |
| If treatment with an immunomodulator fails to prevent severe relapses or disease progression, which drug should you use? | Mitoxantrone |
| What are some side effects of Mitoxantrone? | myelosuppression and heart damage. Only give it to those who really need it. |
| Mitoxantrone is approved for which disorder? | Progressive-Relapsing MS |
| What can Mitoxantrone do? | Mitoxantrone can decrease clinical attack rate, reduce development of new brain lesions, and slow progression of disability. However, although the drug is effective, cardiotoxicity precludes long-term use. |
| How do you treat an acute episode of MS? | A short course of a high-dose IV glucocorticoid is the preferred treatment of an acute relapse. Glucocorticoids suppress inflammation and can thereby reduce the severity and duration of a clinical attack. |
| When do we use IV gamma globulin? | When the patient is intolerant of or unresponsive to glucocorticoids. Results have been good. |
| Seven immunomodulators are available: | glatiramer acetate [Copaxone], natalizumab [Tysabri], fingolimod [Gilenya] and four preparations of interferon beta [Avonex, Rebif, Betaseron, Extavia]. |
| Which MS drugs are used first? | All except for natalizumab. |
| Why is Natalizumab not used first when treating MS? | Why? Because, very rarely, natalizumab has been associated with a potentially fatal infection of the brain. |
| Which of the first line drugs is most effective? | All of the first-line immunomodulators—glatiramer, fingolimod, and the interferon beta preparations—have nearly equal efficacy, decreasing the relapse rate by about 30%. |
| How effective is Natalizumab? | Natalizumab is very effective(decreasing relapse rates to 68% vs. 30%), but is also very dangerous. |
| Route of administration forli first line MS drugs | All are given IM or SQ except Fingolimod. |
| Describe an Interferon beta | Interferon beta is a naturally occurring glycoprotein with antiviral, antiproliferative, and immunomodulatory actions |
| How do Interferon Beta work? | First, it inhibits the migration of proinflammatory leukocytes across the blood-brain barrier, thereby preventing these cells from reaching neurons of the CNS. Second, it suppresses T helper cell activity. |
| What can interferon Beta drugs do? | These drugs can decrease the frequency and severity of attacks, reduce the number and size of MRI-detectable lesions, and delay the progression of disability. |
| What are some adverse reactions of INTEFERON BETA drugs? | Flu-like reactions, Hepatotoxicity, Myelosuppression(bone marrow function supression), Injection-site reactions(pain, erythema, bumps, and itching). |
| Based on the adverse reactions caused by interferon beta drugs, what drugs should be avoided? | Exercise caution when combining interferon beta with other drugs that can suppress the bone marrow or cause liver injury. |
| List all four interferon beta | Avonex, Rebif, Betaseron and extavia |
| Therapeutic use of Glatiramer acetate | Glatiramer acetate [Copaxone], also known as copolymer-1, is used for long-term therapy of relapsing-remitting MS. It does the same things as interferon beta drugs. |
| What are the first line drugs for Ms | glatiramer acetate, natalizumab, fingolimod and four preparations of interferon beta [Avonex, Rebif, Betaseron, Extavia]. |
| What is different about Glatiramer acetate? | Unlike interferon beta, glatiramer does not cause flu-like symptoms, myelosuppression, or liver toxicity. |
| Natalizumab | most effective drug; not used first because if can infect the brain |